Stem definition | Drug id | CAS RN |
---|---|---|
quaternary ammonium compounds | 2776 | 10405-02-4 |
Dose | Unit | Route |
---|---|---|
40 | mg | O |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 3 | Benet LZ, Broccatelli F, Oprea TI |
S (Water solubility) | 500 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 6 % | Benet LZ, Broccatelli F, Oprea TI |
MRTD (Maximum Recommended Therapeutic Daily Dose) | 1.46 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
BA (Bioavailability) | 10 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Vd (Volume of distribution) | 5.10 L/kg | Lombardo F, Berellini G, Obach RS |
CL (Clearance) | 13.90 mL/min/kg | Lombardo F, Berellini G, Obach RS |
fu (Fraction unbound in plasma) | 0.33 % | Lombardo F, Berellini G, Obach RS |
t_half (Half-life) | 5 hours | Lombardo F, Berellini G, Obach RS |
Date | Agency | Company | Orphan |
---|---|---|---|
May 28, 2004 | FDA | ALLERGAN |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Pancreatic steatosis | 114.04 | 19.70 | 25 | 6015 | 991 | 63481991 |
Lymphatic fistula | 103.17 | 19.70 | 22 | 6018 | 764 | 63482218 |
Femoral hernia incarcerated | 101.69 | 19.70 | 22 | 6018 | 819 | 63482163 |
Aortic valve stenosis | 98.13 | 19.70 | 28 | 6012 | 3271 | 63479711 |
Arterial haemorrhage | 95.97 | 19.70 | 24 | 6016 | 1693 | 63481289 |
Wound infection pseudomonas | 91.68 | 19.70 | 22 | 6018 | 1306 | 63481676 |
Seroma | 81.35 | 19.70 | 22 | 6018 | 2109 | 63480873 |
Tachyarrhythmia | 77.43 | 19.70 | 25 | 6015 | 4425 | 63478557 |
Haemarthrosis | 77.10 | 19.70 | 23 | 6017 | 3138 | 63479844 |
Fall | 74.09 | 19.70 | 133 | 5907 | 392201 | 63090781 |
Faecaloma | 73.97 | 19.70 | 28 | 6012 | 7913 | 63475069 |
Wound dehiscence | 71.09 | 19.70 | 24 | 6016 | 4879 | 63478103 |
Urinary tract infection | 70.64 | 19.70 | 105 | 5935 | 264579 | 63218403 |
Diverticulum intestinal | 67.37 | 19.70 | 25 | 6015 | 6688 | 63476294 |
Hepatic cyst | 66.04 | 19.70 | 23 | 6017 | 5131 | 63477851 |
Inflammatory marker increased | 63.29 | 19.70 | 24 | 6016 | 6815 | 63476167 |
Eructation | 62.12 | 19.70 | 25 | 6015 | 8308 | 63474674 |
Aortic arteriosclerosis | 58.21 | 19.70 | 22 | 6018 | 6187 | 63476795 |
Coronary artery disease | 58.16 | 19.70 | 37 | 6003 | 32340 | 63450642 |
Anuria | 55.35 | 19.70 | 26 | 6014 | 12525 | 63470457 |
General physical health deterioration | 55.25 | 19.70 | 81 | 5959 | 201321 | 63281661 |
Lactic acidosis | 54.85 | 19.70 | 38 | 6002 | 38249 | 63444733 |
Hyponatraemia | 54.60 | 19.70 | 60 | 5980 | 111840 | 63371142 |
Cardiovascular disorder | 53.73 | 19.70 | 25 | 6015 | 11787 | 63471195 |
Urinary retention | 52.86 | 19.70 | 34 | 6006 | 30267 | 63452715 |
Mitral valve incompetence | 52.52 | 19.70 | 29 | 6011 | 19565 | 63463417 |
Aplastic anaemia | 52.23 | 19.70 | 23 | 6017 | 9546 | 63473436 |
Labelled drug-drug interaction medication error | 50.73 | 19.70 | 25 | 6015 | 13374 | 63469608 |
Escherichia infection | 48.89 | 19.70 | 24 | 6016 | 12730 | 63470252 |
Groin pain | 47.67 | 19.70 | 22 | 6018 | 10181 | 63472801 |
Left ventricular dysfunction | 47.27 | 19.70 | 23 | 6017 | 11965 | 63471017 |
Postoperative wound infection | 46.23 | 19.70 | 22 | 6018 | 10903 | 63472079 |
Hyperkalaemia | 45.16 | 19.70 | 39 | 6001 | 54164 | 63428818 |
Pulmonary hypertension | 44.35 | 19.70 | 33 | 6007 | 37090 | 63445892 |
Tricuspid valve incompetence | 42.96 | 19.70 | 23 | 6017 | 14598 | 63468384 |
Myelodysplastic syndrome | 42.72 | 19.70 | 24 | 6016 | 16730 | 63466252 |
Acute kidney injury | 40.54 | 19.70 | 82 | 5958 | 263333 | 63219649 |
Hiatus hernia | 39.57 | 19.70 | 25 | 6015 | 21569 | 63461413 |
Joint dislocation | 37.57 | 19.70 | 23 | 6017 | 18777 | 63464205 |
Haematemesis | 36.25 | 19.70 | 27 | 6013 | 30385 | 63452597 |
Cardiogenic shock | 35.99 | 19.70 | 22 | 6018 | 17910 | 63465072 |
Bladder trabeculation | 35.75 | 19.70 | 6 | 6034 | 54 | 63482928 |
Product monitoring error | 35.22 | 19.70 | 14 | 6026 | 4502 | 63478480 |
Haematuria | 35.00 | 19.70 | 26 | 6014 | 29131 | 63453851 |
Fracture | 34.21 | 19.70 | 22 | 6018 | 19562 | 63463420 |
Osteopenia | 34.01 | 19.70 | 22 | 6018 | 19763 | 63463219 |
Therapeutic drug monitoring analysis not performed | 33.67 | 19.70 | 10 | 6030 | 1342 | 63481640 |
Multiple sclerosis relapse | 27.16 | 19.70 | 28 | 6012 | 48450 | 63434532 |
Dry mouth | 26.82 | 19.70 | 35 | 6005 | 77828 | 63405154 |
Oedema peripheral | 26.77 | 19.70 | 57 | 5983 | 189454 | 63293528 |
Face oedema | 26.47 | 19.70 | 19 | 6021 | 20193 | 63462789 |
Portal fibrosis | 26.26 | 19.70 | 6 | 6034 | 287 | 63482695 |
Drug ineffective | 25.17 | 19.70 | 38 | 6002 | 1044727 | 62438255 |
Distal intestinal obstruction syndrome | 24.14 | 19.70 | 6 | 6034 | 412 | 63482570 |
Spinal pain | 23.54 | 19.70 | 15 | 6025 | 13124 | 63469858 |
Gait disturbance | 23.48 | 19.70 | 53 | 5987 | 183125 | 63299857 |
Postmortem blood drug level increased | 21.95 | 19.70 | 6 | 6034 | 598 | 63482384 |
Upper airway obstruction | 21.05 | 19.70 | 6 | 6034 | 697 | 63482285 |
Dementia | 20.87 | 19.70 | 16 | 6024 | 18778 | 63464204 |
Product prescribing error | 20.05 | 19.70 | 18 | 6022 | 26271 | 63456711 |
Left ventricular failure | 19.72 | 19.70 | 10 | 6030 | 5677 | 63477305 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
General physical health deterioration | 74.17 | 25.39 | 71 | 2870 | 128198 | 34825792 |
Product prescribing error | 65.67 | 25.39 | 34 | 2907 | 22893 | 34931097 |
Anticholinergic syndrome | 49.56 | 25.39 | 13 | 2928 | 1256 | 34952734 |
Hyperkinesia | 45.29 | 25.39 | 13 | 2928 | 1755 | 34952235 |
Arteriosclerotic gangrene | 41.73 | 25.39 | 7 | 2934 | 72 | 34953918 |
Bladder spasm | 38.79 | 25.39 | 10 | 2931 | 902 | 34953088 |
Freezing phenomenon | 38.03 | 25.39 | 11 | 2930 | 1525 | 34952465 |
Mucosal haemorrhage | 37.42 | 25.39 | 11 | 2930 | 1614 | 34952376 |
Fall | 35.39 | 25.39 | 62 | 2879 | 202823 | 34751167 |
Skin swelling | 34.80 | 25.39 | 10 | 2931 | 1355 | 34952635 |
Labelled drug-drug interaction medication error | 33.91 | 25.39 | 19 | 2922 | 14920 | 34939070 |
Therapeutic product effect variable | 32.95 | 25.39 | 11 | 2930 | 2445 | 34951545 |
Atrioventricular block second degree | 31.88 | 25.39 | 12 | 2929 | 3776 | 34950214 |
Confusional state | 29.00 | 25.39 | 47 | 2894 | 144113 | 34809877 |
Disorientation | 28.36 | 25.39 | 23 | 2918 | 33165 | 34920825 |
Pallor | 26.86 | 25.39 | 20 | 2921 | 25460 | 34928530 |
Thrombophlebitis | 26.37 | 25.39 | 10 | 2931 | 3212 | 34950778 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
General physical health deterioration | 120.73 | 18.49 | 144 | 7963 | 275094 | 79461187 |
Pancreatic steatosis | 104.04 | 18.49 | 24 | 8083 | 1121 | 79735160 |
Lymphatic fistula | 101.24 | 18.49 | 22 | 8085 | 781 | 79735500 |
Femoral hernia incarcerated | 100.20 | 18.49 | 22 | 8085 | 820 | 79735461 |
Wound infection pseudomonas | 85.86 | 18.49 | 22 | 8085 | 1599 | 79734682 |
Fall | 85.04 | 18.49 | 166 | 7941 | 487463 | 79248818 |
Arterial haemorrhage | 84.87 | 18.49 | 24 | 8083 | 2537 | 79733744 |
Aortic valve stenosis | 83.23 | 18.49 | 28 | 8079 | 5266 | 79731015 |
Labelled drug-drug interaction medication error | 79.95 | 18.49 | 44 | 8063 | 27606 | 79708675 |
Seroma | 78.24 | 18.49 | 22 | 8085 | 2278 | 79734003 |
Faecaloma | 74.96 | 18.49 | 32 | 8075 | 11532 | 79724749 |
Product prescribing error | 74.47 | 18.49 | 50 | 8057 | 44763 | 79691518 |
Wound dehiscence | 69.82 | 18.49 | 26 | 8081 | 6569 | 79729712 |
Urinary tract infection | 66.46 | 18.49 | 108 | 7999 | 274404 | 79461877 |
Urinary retention | 66.13 | 18.49 | 51 | 8056 | 56579 | 79679702 |
Tachyarrhythmia | 64.86 | 18.49 | 25 | 8082 | 6937 | 79729344 |
Haemarthrosis | 61.84 | 18.49 | 23 | 8084 | 5789 | 79730492 |
Diverticulum intestinal | 59.73 | 18.49 | 25 | 8082 | 8580 | 79727701 |
Hepatic cyst | 57.20 | 18.49 | 22 | 8085 | 6067 | 79730214 |
Hyponatraemia | 55.81 | 18.49 | 79 | 8028 | 177769 | 79558512 |
Inflammatory marker increased | 54.40 | 18.49 | 25 | 8082 | 10715 | 79725566 |
Eructation | 54.03 | 18.49 | 25 | 8082 | 10884 | 79725397 |
Escherichia infection | 52.98 | 18.49 | 29 | 8078 | 17988 | 79718293 |
Groin pain | 49.71 | 18.49 | 25 | 8082 | 13055 | 79723226 |
Aortic arteriosclerosis | 49.09 | 18.49 | 22 | 8085 | 8896 | 79727385 |
Cardiovascular disorder | 44.83 | 18.49 | 26 | 8081 | 17999 | 79718282 |
Distal intestinal obstruction syndrome | 43.25 | 18.49 | 11 | 8096 | 776 | 79735505 |
Product monitoring error | 42.83 | 18.49 | 20 | 8087 | 8886 | 79727395 |
Postoperative wound infection | 41.28 | 18.49 | 22 | 8085 | 12939 | 79723342 |
Anuria | 41.20 | 18.49 | 26 | 8081 | 20937 | 79715344 |
Hyperkinesia | 41.19 | 18.49 | 14 | 8093 | 2715 | 79733566 |
Mitral valve incompetence | 40.68 | 18.49 | 29 | 8078 | 28536 | 79707745 |
Arteriosclerotic gangrene | 40.23 | 18.49 | 7 | 8100 | 74 | 79736207 |
Dementia | 39.72 | 18.49 | 27 | 8080 | 24632 | 79711649 |
Lactic acidosis | 39.58 | 18.49 | 42 | 8065 | 70317 | 79665964 |
Gait disturbance | 38.89 | 18.49 | 73 | 8034 | 207433 | 79528848 |
Joint dislocation | 38.37 | 18.49 | 23 | 8084 | 16916 | 79719365 |
Anticholinergic syndrome | 37.36 | 18.49 | 14 | 8093 | 3597 | 79732684 |
Aplastic anaemia | 37.19 | 18.49 | 23 | 8084 | 17882 | 79718399 |
Haematuria | 36.80 | 18.49 | 40 | 8067 | 68796 | 79667485 |
Hiatus hernia | 36.30 | 18.49 | 25 | 8082 | 23287 | 79712994 |
Bladder spasm | 35.28 | 18.49 | 12 | 8095 | 2331 | 79733950 |
Tricuspid valve incompetence | 35.16 | 18.49 | 23 | 8084 | 19689 | 79716592 |
Bladder trabeculation | 34.97 | 18.49 | 6 | 8101 | 58 | 79736223 |
Haematemesis | 34.47 | 18.49 | 34 | 8073 | 52230 | 79684051 |
Disorientation | 34.47 | 18.49 | 37 | 8070 | 62739 | 79673542 |
Osteopenia | 34.16 | 18.49 | 22 | 8085 | 18342 | 79717939 |
Mucosal haemorrhage | 34.12 | 18.49 | 12 | 8095 | 2574 | 79733707 |
Freezing phenomenon | 33.59 | 18.49 | 11 | 8096 | 1903 | 79734378 |
Left ventricular dysfunction | 33.10 | 18.49 | 22 | 8085 | 19339 | 79716942 |
Therapeutic product effect variable | 33.06 | 18.49 | 11 | 8096 | 1998 | 79734283 |
Dizziness | 32.34 | 18.49 | 122 | 7985 | 526319 | 79209962 |
Coronary artery disease | 31.48 | 18.49 | 36 | 8071 | 65438 | 79670843 |
Pallor | 30.14 | 18.49 | 31 | 8076 | 50031 | 79686250 |
Therapeutic drug monitoring analysis not performed | 29.48 | 18.49 | 10 | 8097 | 1926 | 79734355 |
Confusional state | 28.70 | 18.49 | 84 | 8023 | 317913 | 79418368 |
Fracture | 28.46 | 18.49 | 21 | 8086 | 21780 | 79714501 |
Myelodysplastic syndrome | 28.38 | 18.49 | 24 | 8083 | 30277 | 79706004 |
Atrioventricular block second degree | 27.85 | 18.49 | 14 | 8093 | 7298 | 79728983 |
Urogenital haemorrhage | 27.21 | 18.49 | 8 | 8099 | 969 | 79735312 |
Dysuria | 26.17 | 18.49 | 29 | 8078 | 50922 | 79685359 |
Urinary incontinence | 25.84 | 18.49 | 26 | 8081 | 40883 | 79695398 |
Orthostatic intolerance | 25.66 | 18.49 | 9 | 8098 | 1915 | 79734366 |
Pyelonephritis | 25.19 | 18.49 | 19 | 8088 | 20369 | 79715912 |
Subileus | 25.05 | 18.49 | 12 | 8095 | 5642 | 79730639 |
Syncope | 24.02 | 18.49 | 55 | 8052 | 179394 | 79556887 |
Hydronephrosis | 23.20 | 18.49 | 17 | 8090 | 17437 | 79718844 |
Skin swelling | 22.40 | 18.49 | 10 | 8097 | 4004 | 79732277 |
Face oedema | 21.77 | 18.49 | 20 | 8087 | 28116 | 79708165 |
Portal fibrosis | 21.39 | 18.49 | 6 | 8101 | 615 | 79735666 |
Disturbance in attention | 21.22 | 18.49 | 26 | 8081 | 50775 | 79685506 |
Asthenia | 20.94 | 18.49 | 105 | 8002 | 511584 | 79224697 |
Pulmonary hypertension | 20.72 | 18.49 | 25 | 8082 | 48055 | 79688226 |
Drug ineffective | 19.96 | 18.49 | 51 | 8056 | 1080862 | 78655419 |
Postmortem blood drug level increased | 19.82 | 18.49 | 6 | 8101 | 803 | 79735478 |
Nocturia | 19.73 | 18.49 | 14 | 8093 | 13667 | 79722614 |
Fractured sacrum | 19.32 | 18.49 | 7 | 8100 | 1636 | 79734645 |
Pulmonary haematoma | 18.77 | 18.49 | 4 | 8103 | 129 | 79736152 |
Pollakiuria | 18.75 | 18.49 | 21 | 8086 | 37296 | 79698985 |
Hyperkalaemia | 18.67 | 18.49 | 38 | 8069 | 114360 | 79621921 |
None
Source | Code | Description |
---|---|---|
ATC | A03DA06 | ALIMENTARY TRACT AND METABOLISM DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS ANTISPASMODICS IN COMBINATION WITH ANALGESICS Synthetic anticholinergic agents in combination with analgesics |
ATC | G04BD09 | GENITO URINARY SYSTEM AND SEX HORMONES UROLOGICALS UROLOGICALS Drugs for urinary frequency and incontinence |
FDA MoA | N0000000125 | Cholinergic Muscarinic Antagonists |
MeSH PA | D018678 | Cholinergic Agents |
MeSH PA | D018680 | Cholinergic Antagonists |
MeSH PA | D018727 | Muscarinic Antagonists |
MeSH PA | D018377 | Neurotransmitter Agents |
MeSH PA | D010276 | Parasympatholytics |
MeSH PA | D018373 | Peripheral Nervous System Agents |
MeSH PA | D064804 | Urological Agents |
FDA EPC | N0000175700 | Cholinergic Muscarinic Antagonist |
CHEBI has role | CHEBI:48876 | muscarinic antagonists |
CHEBI has role | CHEBI:53784 | antispasmodics |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Urgent desire to urinate | indication | 75088002 | |
Urge incontinence of urine | indication | 87557004 | |
Bladder muscle dysfunction - overactive | indication | 236633002 | |
Increased Urinary Frequency | indication | ||
Constipation | contraindication | 14760008 | DOID:2089 |
Atony of colon | contraindication | 29479008 | |
Acute nephropathy | contraindication | 58574008 | |
Ulcerative colitis | contraindication | 64766004 | DOID:8577 |
Myasthenia gravis | contraindication | 91637004 | DOID:437 |
Gastrointestinal obstruction | contraindication | 126765001 | |
Disease of liver | contraindication | 235856003 | DOID:409 |
Bladder outflow obstruction | contraindication | 236645006 | |
Retention of urine | contraindication | 267064002 | |
Gastric retention | contraindication | 307227006 | |
Angle-closure glaucoma | contraindication | 392291006 | DOID:13550 |
Gastrointestinal hypomotility | contraindication | 421807004 |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 13.67 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Muscarinic acetylcholine receptor M2 | GPCR | ANTAGONIST | Ki | 8.94 | CHEMBL | CHEMBL | |||
Muscarinic acetylcholine receptor M3 | GPCR | ANTAGONIST | Ki | 8.99 | CHEMBL | CHEMBL | |||
Muscarinic acetylcholine receptor M1 | GPCR | Ki | 8.46 | CHEMBL | |||||
Muscarinic acetylcholine receptor M4 | GPCR | Ki | 8.84 | CHEMBL | |||||
Muscarinic acetylcholine receptor M5 | GPCR | Ki | 8.22 | CHEMBL |
ID | Source |
---|---|
4021473 | VUID |
N0000148857 | NUI |
D01103 | KEGG_DRUG |
4021473 | VANDF |
C0772089 | UMLSCUI |
CHEBI:32270 | CHEBI |
CHEMBL1888176 | ChEMBL_ID |
DB00209 | DRUGBANK_ID |
CHEMBL3084748 | ChEMBL_ID |
C003330 | MESH_SUPPLEMENTAL_RECORD_UI |
5284632 | PUBCHEM_CID |
7480 | IUPHAR_LIGAND_ID |
T4Y8ORK057 | UNII |
236778 | RXNORM |
107689 | MMSL |
17758 | MMSL |
d04929 | MMSL |
006793 | NDDF |
006794 | NDDF |
326557004 | SNOMEDCT_US |
359380005 | SNOMEDCT_US |
412604005 | SNOMEDCT_US |
3001 | INN_ID |
47608-32-2 | SECONDARY_CAS_RN |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Trospium ChlorideER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0574-0118 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 29 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0574-0145 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 30 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0591-3636 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 26 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0904-7059 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 21 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 23155-530 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 20 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 23155-530 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 20 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 23155-530 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 20 sections |
TROSPIUM CHLORIDE ER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 35573-446 | CAPSULE | 60 mg | ORAL | ANDA | 26 sections |
TROSPIUM CHLORIDE ER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 35573-446 | CAPSULE | 60 mg | ORAL | ANDA | 26 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-5994 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 22 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 60429-098 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 26 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 62135-742 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 19 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-8457 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 29 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-8457 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 29 sections |
Trospium ChlorideER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-8458 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 28 sections |
Trospium ChlorideER | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-8458 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 28 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 63629-9279 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 29 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 68001-427 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 26 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 68462-461 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 29 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 68462-461 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 29 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69097-912 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 28 sections |
Trospium Chloride | HUMAN PRESCRIPTION DRUG LABEL | 1 | 69150-258 | TABLET | 20 mg | ORAL | ANDA | 28 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 70010-027 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 26 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 70010-027 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 26 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 70436-174 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 22 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 70436-174 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 22 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 70436-174 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 22 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 71205-917 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 26 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 71205-917 | CAPSULE, EXTENDED RELEASE | 60 mg | ORAL | ANDA | 26 sections |
TROSPIUM CHLORIDE | HUMAN PRESCRIPTION DRUG LABEL | 1 | 72789-348 | TABLET, FILM COATED | 20 mg | ORAL | ANDA | 30 sections |